Your most critical assets deserve more than just fences and cameras. NV5’s cutting-edge layered security solutions extend detection and response beyond traditional perimeters. From advanced geospatial analytics to integrated surveillance and access control, NV5 helps you stay ahead of threats before they breach your defenses. Learn more.

November 1, 2022, 1:27PMNuclear News

Bruce's Unit 7 is now producing Lutetium-177, used in targeted cancer therapeutics. (Photo: Bruce Power)

An international collaboration between Bruce Power, Isogen (a Kinectrics and Framatome company), and ITM Isotope Technologies Munich SE (ITM) announced they have begun commercial production of lutetium-177 using Unit 7 of the Bruce nuclear power plant in Kincardine, Ontario. According to the companies, this marks the first time a commercial power reactor has been used to commercially produce short-lived medical radioisotopes.

To continue reading, log in or create a free account!

Clarity and Nusano agree on medical isotopes deal

October 30, 2025, 7:00AMNuclear News

Australia-based Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, has signed a supply agreement for copper-67 with Nusano, Inc., headquartered in California. Nusano...

NN Asks: What did you learn from ANS’s Nuclear 101?

September 15, 2025, 12:00PMNuclear NewsMike Harkin

When ANS first announced its new Nuclear 101 certificate course, I was excited. This felt like a course tailor-made for me, a transplant into the commercial nuclear world. I enrolled for the...

Constellation appoints new nuclear chief

September 5, 2025, 7:01AMNuclear News

Longtime nuclear industry executive Chris Mudrick has been named the new chief nuclear officer at Constellation Energy, effective September 29. He will take over the position from Dave...

My Story: Alan Levin, ANS member since 1980

August 12, 2025, 9:30AMNuclear NewsAlan Levin

Growing up in Baltimore in the 1950s and ’60s, I had interests in two areas that ultimately had major impacts on my education and career. The first was science—especially nuclear...

Orano Med expands its Texas Pb-212 R&D center

June 27, 2025, 12:47PMNuclear News

Orano Group subsidiary Orano Med, a developer of targeted alpha therapies for oncology, inaugurated the expansion of its main research and development center located in Plano, Texas. The...

ANS holds Educator Training webinar on nuclear waste

May 16, 2025, 7:00AMANS News

A recent American Nuclear Society webinar tackled misconceptions about nuclear waste. Christopher Perfetti, an associate professor of nuclear engineering at the University of New Mexico,...

SHINE to acquire Lantheus’s SPECT business line

May 9, 2025, 7:01AMNuclear News

SHINE Technologies, a fusion company building what is set to be the world’s largest medical isotope production facility at its Wisconsin campus, announced that it has agreed to acquire the...

Oak Ridge’s Isotek dramatically increases world supply of Th-229

May 7, 2025, 12:02PMNuclear News

Workers with Oak Ridge Office of Environmental Management contractor Isotek have surpassed a significant milestone in the supply of medical radioisotopes, extracting more than 15 grams of rare...

Framatome opens new fuel workshop for research reactors and medical targets

April 24, 2025, 7:56AMNuclear News

Framatome announced that it has inaugurated a new workshop dedicated to the fabrication of fuel for research reactors and targets for medical isotopes at the company’s Romans-sur-Isère site...

Higher enriched nuclear fuel being tested at Vogtle

April 11, 2025, 12:07PMNuclear News

Southern Nuclear recently loaded nuclear fuel with uranium-235 enriched up to 6 percent—higher than the usual 3–5 percent enrichment—into Vogtle-2 to test it through irradiation....

Lu-177 production begins at Canada’s Bruce NPP

Related Articles